Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-25 FOEHR MATTHEW W President and COO Grant or award +2,911 158,324
2021-01-25 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,053 $156.01 $164K 157,271
2021-01-25 FOEHR MATTHEW W President and COO Grant or award +5,604 162,875
2021-01-25 FOEHR MATTHEW W President and COO Shares withheld for taxes −2,272 $156.01 $354K 160,603
2021-01-25 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +2,305 28,241
2021-01-25 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −671 $156.01 $105K 27,570
2021-01-25 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +4,803 32,373
2021-01-25 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −1,440 $156.01 $225K 30,933
2021-01-25 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +1,335 42,450
2021-01-25 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −509 $156.10 $79K 41,941
2021-01-25 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +2,401 44,342
2021-01-25 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −830 $156.01 $129K 43,512
2020-12-31 HIGGINS JOHN L Chief Executive Officer Other acquisition +223 $84.53 $19K 235,310
2020-12-08 HIGGINS JOHN L Chief Executive Officer Option exercise +14,657 $10.05 $147K 236,770
2020-12-08 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −1,683 $87.52 $147K 235,087
2020-12-08 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −14,657 60,000
2020-11-09 HIGGINS JOHN L Chief Executive Officer Option exercise +20,000 $10.05 $201K 224,571
2020-11-09 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −2,458 $81.77 $201K 222,113
2020-11-09 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −20,000 74,657
2020-11-02 Patel Sunil Director Purchase +1,000 $82.52 $83K 28,190

Page 37 of 43 · 858 trades